Selected research
Industry Research
Drug Testing Industry Research Report 2026
Market perspective
The global Drug Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Testing include Siemens Healthcare, Thermo Fisher Scientific, Roche Diagnostics, Quest Diagnostics, Shimadzu, Quest Diagnostics, Laboratory Corporation of America MPD, KGAA Alere and Express Diagnostics and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Testing Market by Company
Siemens Healthcare
Thermo Fisher Scientific
Roche Diagnostics
Quest Diagnostics
Shimadzu
Quest Diagnostics
Laboratory Corporation of America MPD
KGAA Alere
Express Diagnostics
Drgerwerk AG & Co.
Drug Testing Segment by Type
Hair Sample
Breath Sample
Oral Fluid
Urine Sample
Others
Drug Testing Segment by Application
Personal Users
Workplace and Schools
Pain Management Centers
Criminal Justice System & Law Enforcement Agencies
Drug Testing Laboratories
Drug Treatment Centers
Hospitals
Drug Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hair Sample
- Breath Sample
- Oral Fluid
- Urine Sample
- Others
Applications
- Personal Users
- Workplace and Schools
- Pain Management Centers
- Criminal Justice System & Law Enforcement Agencies
- Drug Testing Laboratories
- Drug Treatment Centers
- Hospitals
Companies covered
- Siemens Healthcare
- Thermo Fisher Scientific
- Roche Diagnostics
- Quest Diagnostics
- Shimadzu
- Quest Diagnostics
- Laboratory Corporation of America MPD
- KGAA Alere
- Express Diagnostics
- Drgerwerk AG & Co.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hair Sample
- 2.2.3 Breath Sample
- 2.2.4 Oral Fluid
- 2.2.5 Urine Sample
- 2.2.6 Others
- 2.3 Drug Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Personal Users
- 2.3.3 Workplace and Schools
- 2.3.4 Pain Management Centers
- 2.3.5 Criminal Justice System & Law Enforcement Agencies
- 2.3.6 Drug Testing Laboratories
- 2.3.7 Drug Treatment Centers
- 2.3.8 Hospitals
- 2.4 Assumptions and Limitations
3 Drug Testing Breakdown Data by Type
- 3.1 Global Drug Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Testing Forecasted Market Size by Type (2027-2032)
4 Drug Testing Breakdown Data by Application
- 4.1 Global Drug Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Testing Market Perspective (2021-2032)
- 5.2 Global Drug Testing Growth Trends by Region
- 5.2.1 Global Drug Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Testing Market Dynamics
- 5.3.1 Drug Testing Industry Trends
- 5.3.2 Drug Testing Market Drivers
- 5.3.3 Drug Testing Market Challenges
- 5.3.4 Drug Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Testing Players by Revenue
- 6.1.1 Global Top Drug Testing Players by Revenue (2021-2026)
- 6.1.2 Global Drug Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Testing Head Office and Area Served
- 6.4 Global Drug Testing Players, Product Type & Application
- 6.5 Global Drug Testing Manufacturers Established Date
- 6.6 Global Drug Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Testing Market Size (2021-2032)
- 7.2 North America Drug Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Testing Market Size by Country (2021-2026)
- 7.4 North America Drug Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Testing Market Size (2021-2032)
- 8.2 Europe Drug Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Testing Market Size by Country (2021-2026)
- 8.4 Europe Drug Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Testing Market Size (2021-2032)
- 10.2 South America Drug Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Testing Market Size by Country (2021-2026)
- 10.4 South America Drug Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Siemens Healthcare
- 12.1.1 Siemens Healthcare Company Information
- 12.1.2 Siemens Healthcare Business Overview
- 12.1.3 Siemens Healthcare Revenue in Drug Testing Business (2021-2026)
- 12.1.4 Siemens Healthcare Drug Testing Product Portfolio
- 12.1.5 Siemens Healthcare Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Drug Testing Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Drug Testing Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Roche Diagnostics
- 12.3.1 Roche Diagnostics Company Information
- 12.3.2 Roche Diagnostics Business Overview
- 12.3.3 Roche Diagnostics Revenue in Drug Testing Business (2021-2026)
- 12.3.4 Roche Diagnostics Drug Testing Product Portfolio
- 12.3.5 Roche Diagnostics Recent Developments
- 12.4 Quest Diagnostics
- 12.4.1 Quest Diagnostics Company Information
- 12.4.2 Quest Diagnostics Business Overview
- 12.4.3 Quest Diagnostics Revenue in Drug Testing Business (2021-2026)
- 12.4.4 Quest Diagnostics Drug Testing Product Portfolio
- 12.4.5 Quest Diagnostics Recent Developments
- 12.5 Shimadzu
- 12.5.1 Shimadzu Company Information
- 12.5.2 Shimadzu Business Overview
- 12.5.3 Shimadzu Revenue in Drug Testing Business (2021-2026)
- 12.5.4 Shimadzu Drug Testing Product Portfolio
- 12.5.5 Shimadzu Recent Developments
- 12.6 Quest Diagnostics
- 12.6.1 Quest Diagnostics Company Information
- 12.6.2 Quest Diagnostics Business Overview
- 12.6.3 Quest Diagnostics Revenue in Drug Testing Business (2021-2026)
- 12.6.4 Quest Diagnostics Drug Testing Product Portfolio
- 12.6.5 Quest Diagnostics Recent Developments
- 12.7 Laboratory Corporation of America MPD
- 12.7.1 Laboratory Corporation of America MPD Company Information
- 12.7.2 Laboratory Corporation of America MPD Business Overview
- 12.7.3 Laboratory Corporation of America MPD Revenue in Drug Testing Business (2021-2026)
- 12.7.4 Laboratory Corporation of America MPD Drug Testing Product Portfolio
- 12.7.5 Laboratory Corporation of America MPD Recent Developments
- 12.8 KGAA Alere
- 12.8.1 KGAA Alere Company Information
- 12.8.2 KGAA Alere Business Overview
- 12.8.3 KGAA Alere Revenue in Drug Testing Business (2021-2026)
- 12.8.4 KGAA Alere Drug Testing Product Portfolio
- 12.8.5 KGAA Alere Recent Developments
- 12.9 Express Diagnostics
- 12.9.1 Express Diagnostics Company Information
- 12.9.2 Express Diagnostics Business Overview
- 12.9.3 Express Diagnostics Revenue in Drug Testing Business (2021-2026)
- 12.9.4 Express Diagnostics Drug Testing Product Portfolio
- 12.9.5 Express Diagnostics Recent Developments
- 12.10 Drgerwerk AG & Co.
- 12.10.1 Drgerwerk AG & Co. Company Information
- 12.10.2 Drgerwerk AG & Co. Business Overview
- 12.10.3 Drgerwerk AG & Co. Revenue in Drug Testing Business (2021-2026)
- 12.10.4 Drgerwerk AG & Co. Drug Testing Product Portfolio
- 12.10.5 Drgerwerk AG & Co. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst